By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Fluvastatin

Fluvastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
4 Min Read
SHARE
3 min read|556 words

Fluvastatin Drug Profile

What is Fluvastatin?

Fluvastatin is a cholesterol-lowering medication belonging to a class of drugs called statins. It is primarily prescribed to reduce high cholesterol levels and lower the risk of cardiovascular disease in patients with elevated blood lipid levels. Fluvastatin works by blocking an enzyme that the body needs to produce cholesterol.

Uses

Fluvastatin is approved for several cardiovascular conditions:

  • High cholesterol (hypercholesterolemia): Reduces LDL (“bad”) cholesterol and total cholesterol levels in patients with primary hypercholesterolemia
  • Mixed dyslipidemia: Treats patients with elevated cholesterol and triglyceride levels when dietary changes alone are insufficient
  • Cardiovascular disease prevention: Reduces risk of heart attack and stroke in patients with existing coronary heart disease
  • Post-cardiac procedure care: Helps prevent cardiovascular events following coronary revascularization procedures like angioplasty
  • Familial hypercholesterolemia: Manages inherited forms of high cholesterol in both adults and adolescents

How it works

Fluvastatin inhibits HMG-CoA reductase, an enzyme that plays a crucial role in cholesterol production in the liver. By blocking this enzyme, the medication reduces the amount of cholesterol the body manufactures naturally. This leads to lower blood cholesterol levels and may also have anti-inflammatory effects on blood vessels that contribute to cardiovascular protection.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle aches or weakness
  • Abdominal pain
  • Nausea
  • Diarrhea
  • Upper respiratory tract infection
  • Dizziness
  • Fatigue

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (possible rhabdomyolysis)
  • Dark-colored urine
  • Yellowing of skin or eyes (signs of liver problems)
  • Unexplained muscle cramps with fever
  • Severe abdominal pain

Warnings and precautions

  • Liver function monitoring: Regular liver enzyme tests are recommended, as statins can occasionally cause liver damage
  • Muscle toxicity risk: Patients should report unexplained muscle pain, as rare but serious muscle breakdown (rhabdomyolysis) can occur
  • Pregnancy and breastfeeding: Fluvastatin is contraindicated during pregnancy and breastfeeding due to potential harm to the developing fetus
  • Kidney disease: Patients with severe kidney impairment may require dosage adjustments or alternative treatments
  • Age considerations: Elderly patients may be more susceptible to muscle-related side effects and require careful monitoring

Interactions

Fluvastatin can interact with several medications and substances:

  • Warfarin: May increase bleeding risk by enhancing warfarin’s anticoagulant effects
  • Cyclosporine: Increases fluvastatin levels, raising the risk of muscle toxicity
  • Fibrates (gemfibrozil, fenofibrate): Combined use increases muscle damage risk
  • Rifampin: Significantly reduces fluvastatin effectiveness by increasing its metabolism
  • Fluconazole: Antifungal medication that can increase fluvastatin blood levels
  • Glyburide: Diabetes medication levels may be increased when combined with fluvastatin
  • Alcohol: Excessive alcohol consumption may increase liver toxicity risk
  • Grapefruit juice: While less significant than with other statins, may still slightly increase fluvastatin levels

Check interactions with the GMJ Interaction Checker

Dosage

Adult dosing typically ranges from 20mg to 80mg taken once daily in the evening, as cholesterol production peaks at night. The starting dose is usually 20mg daily, with adjustments made based on cholesterol response and tolerance. Extended-release formulations may be taken once daily without regard to meals, while immediate-release capsules are best taken in the evening. Maximum recommended dose is 80mg daily. Dosage should always be individualized and determined by a healthcare provider based on the patient’s specific condition, response to treatment, and other medications being taken.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Fluvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/fluvastatin-2/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Lovastatin

By
GMJ News Desk
01/06/2026

Simvastatin

By
GMJ News Desk
01/06/2026

Pravastatin

By
GMJ News Desk
01/06/2026

Atorvastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up